Articles

Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease

Laboratory of Hematology, GIGA-I3, University of Liège, Belgium
Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria
Laboratory of Hematology, GIGA-I3, University of Liège, Belgium
Laboratory of Hematology, GIGA-I3, University of Liège, Belgium
Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria
PEPs (Products, Environments, Processes), Chemical Engineering, Liège, Belgium
Laboratory of Hematology, GIGA-I3, University of Liège, Belgium
PEPs (Products, Environments, Processes), Chemical Engineering, Liège, Belgium
INSERM-UMR-1132, Université Paris Diderot, France
Institute of Physiological Chemistry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany
Laboratory of Hematology, GIGA-I3, University of Liège, Belgium;Department of Hematology, CHU de Liège, Belgium
Laboratory of Hematology, GIGA-I3, University of Liège, Belgium;Department of Hematology, CHU de Liège, Belgium
INSERM-UMR-1132, Université Paris Diderot, France
Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria
Laboratory of Hematology, GIGA-I3, University of Liège, Belgium
Laboratory of Hematology, GIGA-I3, University of Liège, Belgium;Department of Hematology, CHU de Liège, Belgium
Vol. 103 No. 8 (2018): August, 2018 https://doi.org/10.3324/haematol.2017.185397